Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eneida Nemecek
Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients With Non-Malignant Diseases: Preliminary Results of a Phase II Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases
Bone Marrow Transplantation
Transplantation
Hematology
Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase I-Ii Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Non-Myeloablative Conditioning With Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia
Haematologica
Hematology
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Evaluation of Chimerism Dynamics After Allogeneic Hematopoietic Stem Cell Transplantation in Children With Non-Malignant Diseases.
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Health Care Utilization and Cost of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children With Malignant and Non-Malignant Diseases
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Stem Cell Transplantation After Conditioning With Treosulfan, Etoposide and Cyclophosphamide for Patients With ALL: A Phase II-study on Behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)
Bone Marrow Transplantation
Transplantation
Hematology
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With Fludarabine/Melphalan in Patients With Myelofibrosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
